3/5
05:03 pm
asnd
Ascendis Pharma A/S (ASND) had its "buy" rating reaffirmed by Bank of America Corporation.
Low
Report
Ascendis Pharma A/S (ASND) had its "buy" rating reaffirmed by Bank of America Corporation.
3/3
10:33 am
asnd
Rating for ASND
Low
Report
Rating for ASND
3/3
10:33 am
asnd
Rating for ASND
Low
Report
Rating for ASND
3/2
09:02 pm
asnd
Ascendis Pharma A/S (ASND) had its "outperform" rating reaffirmed by Royal Bank Of Canada.
Low
Report
Ascendis Pharma A/S (ASND) had its "outperform" rating reaffirmed by Royal Bank Of Canada.
3/2
09:02 pm
asnd
Ascendis Pharma A/S (ASND) had its "outperform" rating reaffirmed by Royal Bank Of Canada.
Low
Report
Ascendis Pharma A/S (ASND) had its "outperform" rating reaffirmed by Royal Bank Of Canada.
3/2
01:05 pm
asnd
Ascendis Pharma A/S (ASND) had its "overweight" rating reaffirmed by Cantor Fitzgerald.
Low
Report
Ascendis Pharma A/S (ASND) had its "overweight" rating reaffirmed by Cantor Fitzgerald.
3/2
01:05 pm
asnd
Ascendis Pharma A/S (ASND) had its "outperform" rating reaffirmed by Wolfe Research.
Low
Report
Ascendis Pharma A/S (ASND) had its "outperform" rating reaffirmed by Wolfe Research.
3/2
01:05 pm
asnd
Ascendis Pharma A/S (ASND) had its "outperform" rating reaffirmed by Wolfe Research.
Low
Report
Ascendis Pharma A/S (ASND) had its "outperform" rating reaffirmed by Wolfe Research.
2/12
11:59 am
asnd
Rating for ASND
Low
Report
Rating for ASND
2/12
11:59 am
asnd
Rating for ASND
Low
Report
Rating for ASND
2/12
09:39 am
asnd
Rating for ASND
Low
Report
Rating for ASND
2/12
09:39 am
asnd
Rating for ASND
Low
Report
Rating for ASND
2/12
09:02 am
asnd
Ascendis Pharma A/S (NASDAQ:ASND) had its "outperform" rating reaffirmed by analysts at Oppenheimer Holdings, Inc..
Medium
Report
Ascendis Pharma A/S (NASDAQ:ASND) had its "outperform" rating reaffirmed by analysts at Oppenheimer Holdings, Inc..
2/12
08:04 am
asnd
Ascendis Pharma A/S (NASDAQ:ASND) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Medium
Report
Ascendis Pharma A/S (NASDAQ:ASND) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
2/12
08:04 am
asnd
Ascendis Pharma A/S (NASDAQ:ASND) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Medium
Report
Ascendis Pharma A/S (NASDAQ:ASND) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
1/29
07:41 am
asnd
Ascendis Pharma A/S (NASDAQ:ASND) was upgraded by analysts at Barclays PLC to a "strong-buy" rating.
Low
Report
Ascendis Pharma A/S (NASDAQ:ASND) was upgraded by analysts at Barclays PLC to a "strong-buy" rating.
1/28
09:32 am
asnd
Rating for ASND
Medium
Report
Rating for ASND
1/28
09:32 am
asnd
Rating for ASND
Medium
Report
Rating for ASND
1/27
06:00 pm
asnd
Ascendis Pharma A/S (NASDAQ:ASND) is now covered by analysts at Barclays PLC. They set an "overweight" rating on the stock.
Medium
Report
Ascendis Pharma A/S (NASDAQ:ASND) is now covered by analysts at Barclays PLC. They set an "overweight" rating on the stock.
1/27
04:23 pm
asnd
Ascendis Pharma initiated with an Overweight at Barclays
Medium
Report
Ascendis Pharma initiated with an Overweight at Barclays
1/27
04:23 pm
asnd
Ascendis Pharma initiated with an Overweight at Barclays
Medium
Report
Ascendis Pharma initiated with an Overweight at Barclays
1/20
11:01 am
asnd
Rating for ASND
Medium
Report
Rating for ASND
1/20
11:01 am
asnd
Rating for ASND
Medium
Report
Rating for ASND
1/20
10:47 am
asnd
Rating for ASND
Medium
Report
Rating for ASND
1/20
10:47 am
asnd
Rating for ASND
Medium
Report
Rating for ASND